The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Detailed Analysis of Structures and Formulations of Cationic Lipids for Efficient Gene Transfer to the Lung
Abstract
Cationic lipid-mediated gene transfer of cystic fibrosis transmembrane conductance regulator (CFTR) cDNA represents a promising approach for treatment of cystic fibrosis (CF). Here, we report on the structures of several novel cationic lipids that are effective for gene delivery to the lungs of mice. An amphiphile (#67) consisting of a cholesterol anchor linked to a spermine headgroup in a “T-shape” configuration was shown to be particularly efficacious. An optimized formulation of #67 and plasmid vector encoding chloramphenicol acetyl-transferase (CAT) was capable of generating up to 1 μg of CAT enzyme/lung following intranasal instillation into BALB/c mice. This represents a 1,000-fold increase in expression above that obtained in animals instilled with naked pDNA alone and is greater than 100-fold more active than cationic lipids used previously for CFTR gene expression. When directly compared with adenovirus-based vectors containing similar transcription units, the number of molecules of gene product expressed using lipid-mediated transfer was equivalent to vector administration at multiplicities of infection ranging from 1 to 20. The level of transgene expression in the lungs of BALB/c mice peaked between days 1 and 4 post-instillation, followed by a rapid decline to approximately 20% of the maximal value by day 7. Undiminished levels of transgene expression in the lung could be obtained following repeated intranasal administration of #67:DOPE:pCF1-CAT in nude mice. Transfection of cells with formulations of #67:DOPE:pCF1-CFTR generated cAMP-stimulated CFTR chloride channel and fluid transport activities, two well-characterized defects associated with CF cells. Taken together, the data demonstrate that cationic lipid-mediated gene delivery and expression of CFTR in CF lungs is a viable and promising approach for treatment of the disease. Cationic lipids are being evaluated in the clinic to treat the lung disease of cystic fibrosis (CF) patients. This study reports on our efforts to identify cationic lipids that are more potent and more efficient at delivering the cystic fibrosis transmembrane conductance regulator (CFTR) cDNA to the airway epithelia. By systematic analysis of a large number of different cationic lipid structures, we were able to observe some structure–activity relationships. Determination of what constitutes an active cationic lipid could allow a better understanding of the mechanism of cationic lipid-mediated gene transfer and lead to the design of improved second generation molecules. Several comparative studies indicated that the optimal cationic lipid:pDNA formulations described here were performing at levels comparable to those attained with recombinant adenovirus vectors at low multiplicities of infection. These data support the use of cationic lipids for human gene therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.
Gorman, C. M., Moffat, L. F., & Howard, B. H. (1982) · Molecular and Cellular Biology · doi:10.1128/mcb.2.9.1044 · Cited by 7,830
Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure.
Felgner, P. L., Gadek, T. R., Holm, M., Roman, R., Chan, H. W., Wenz, M., Northrop, J. P., Ringold, G. M., & Danielsen, M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7413 · Cited by 4,978
Direct Gene Transfer into Mouse Muscle in Vivo
Wolff, J. A., Malone, R. W., Williams, P., Chong, W., Acsadi, G., Jani, A., & Felgner, P. L. (1990) · Science · doi:10.1126/science.1690918 · Cited by 4,173 · cited 1×
“…that free p D NA was able to transfect the akway cells in vivo was not totally unexpected because otii ers have shown this activity m muscle (Wolff et al, 1990) and other tissues (Liu et al. 1995), but die observations here and those of Meyer et al. (1995) argue diat inclusion of free p D…”
Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations.
Felgner, J. H., Kumar, R., Sridhar, C. N., Wheeler, C. J., Tsai, Y. J., Border, R., Ramsey, P., Martin, M., & Felgner, P. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41980-6 · Cited by 1,312
A novel cationic liposome reagent for efficient transfection of mammalian cells
Gao, X., & Huang, L. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)91366-k · Cited by 847
The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer
Farhood, H., Serbina, N., & Huang, L. (1995) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(95)80016-9 · Cited by 798
Efficient gene transfer into mammalian primary endocrine cells with lipopolyamine-coated DNA.
Behr, J. P., Demeneix, B., Loeffler, J. P., & Perez-Mutul, J. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.18.6982 · Cited by 719
Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis
Caplen, N. J., Alton, E. W. F. W., Mddleton, P. G., Dorin, J. R., Stevenson, B. J., Gao, X., Durham, S. R., Jeffery, P. K., Hodson, M. E., Coutelle, C., et al. (1995) · Nature Medicine · doi:10.1038/nm0195-39 · Cited by 711
Zabner, J., Couture, L. A., Gregory, R. J., Graham, S. M., Smith, A. E., & Welsh, M. J. (1993) · Cell · doi:10.1016/0092-8674(93)80063-k · Cited by 681
Self-citationCationic liposome-mediated gene transfer.
Gao, X., & Huang, L. (1995) · PubMed · Cited by 619
Cited by
Lipid nanoparticles for mRNA delivery
Hou, X., Zaks, T., Langer, R., & Dong, Y. (2021) · Nature Reviews Materials · doi:10.1038/s41578-021-00358-0 · Cited by 4,076
Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
Kranz, L. M., Diken, M., Haas, H., Kreiter, S., Loquai, C., Reuter, K. C., Meng, M., Fritz, D., Vascotto, F., Hefesha, H., et al. (2016) · Nature · doi:10.1038/nature18300 · Cited by 1,819
Improved DNA: liposome complexes for increased systemic delivery and gene expression
Templeton, N. S., Lasic, D. D., Frederik, P. M., Strey, H. H., Roberts, D. D., & Pavlakis, G. N. (1997) · Nature Biotechnology · doi:10.1038/nbt0797-647 · Cited by 740
An overview of current delivery systems in cancer gene therapy
El-Aneed, A. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.09.013 · Cited by 693
Nonviral gene therapy: promises and challenges
Li, S., & Huang, L. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301110 · Cited by 614
Köping-Höggård, M., Tubulekas, I., Guan, H., Edwards, K., Nilsson, M., Vårum, K., & Artursson, P. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301492 · Cited by 532
Key issues in non-viral gene delivery
Pouton, C. W., & Seymour, L. W. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00048-9 · Cited by 440
Alton, E., Stern, M., Farley, R., Jaffe, A., Chadwick, S., Phillips, J., Davies, J., Smith, S., Browning, J., Davies, M., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)06532-5 · Cited by 435
Self-citationNonviral gene delivery: What we know and what is next
Gao, X., Kim, K.-S., & Liu, D. (2007) · The AAPS Journal · doi:10.1208/aapsj0901009 · Cited by 431
Li, Z., Zhao, R., Wu, X., Sun, Y., Yao, M., Li, J., Xu, Y., & Gu, J. (2005) · The FASEB Journal · doi:10.1096/fj.05-4058com · Cited by 419
Characterization of cationic lipid-protamine–DNA (LPD) complexes for intravenous gene delivery
Li, S., Rizzo, M., Bhattacharya, S., & Huang, L. (1998) · Gene Therapy · doi:10.1038/sj.gt.3300683 · Cited by 369
Cationic lipid–DNA complexes in gene delivery: from biophysics to biological applications
Pedroso de Lima, M. C., Simões, S., Pires, P., Faneca, H., & Düzgüneş, N. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00110-7 · Cited by 365
Polycation-based DNA complexes for tumor-targeted gene deliveryin vivo
Kircheis, R., Schüller, S., Brunner, S., Ogris, M., Heider, K.-H., Zauner, W., & Wagner, E. (1999) · The Journal of Gene Medicine · doi:10.1002/(sici)1521-2254(199903/04)1:2<111::aid-jgm22>3.0.co;2-y · Cited by 356
Li, S., Tseng, W.-C., Stolz, D. B., Wu, S.-P., Watkins, S. C., & Huang, L. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300865 · Cited by 351
Lipid-Based DNA Therapeutics: Hallmarks of Non-Viral Gene Delivery
Buck, J., Grossen, P., Cullis, P. R., Huwyler, J., & Witzigmann, D. (2019) · ACS Nano · doi:10.1021/acsnano.8b07858 · Cited by 312
Polymers for siRNA Delivery: Inspired by Viruses to be Targeted, Dynamic, and Precise
Wagner, E. (2012) · Accounts of Chemical Research · doi:10.1021/ar2002232 · Cited by 308
The Design of Cationic Lipids for Gene Delivery
Martin, B., Sainlos, M., Aissaoui, A., Oudrhiri, N., Hauchecorne, M., Vigneron, J., Lehn, J., & Lehn, P. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612053382133 · Cited by 302
Characterization of Cationic Liposome-Mediated Gene Transfer In Vivo by Intravenous Administration
Song, Y. K., Liu, F., Chu, S., & Liu, D. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.13-1585 · Cited by 297
Pouton, C. W., & Seymour, L. W. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00133-2 · Cited by 291
Karmali, P. P., & Chaudhuri, A. (2007) · Medicinal Research Reviews · doi:10.1002/med.20090 · Cited by 289
Cationic liposomes for gene delivery
Simões, S., Filipe, A., Faneca, H., Mano, M., Penacho, N., Düzgünes, N., & Pedroso de Lima, M. (2005) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2.2.237 · Cited by 285
Stabilization of poly-l-lysine/DNA polyplexes for in vivo gene delivery to the liver
Kwoh, D. Y., Coffin, C. C., Lollo, C. P., Jovenal, J., Banaszczyk, M. G., Mullen, P., Phillips, A., Amini, A., Fabrycki, J., Bartholomew, R. M., et al. (1999) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(98)00274-7 · Cited by 276
The Headgroup Evolution of Cationic Lipids for Gene Delivery
Zhi, D., Zhang, S., Cui, S., Zhao, Y., Wang, Y., & Zhao, D. (2013) · Bioconjugate Chemistry · doi:10.1021/bc300381s · Cited by 271
Advances in gene delivery through molecular design of cationic lipids
Bhattacharya, S., & Bajaj, A. (2009) · Chemical Communications · doi:10.1039/b900666b · Cited by 264
Efficient gene transfer to airway epithelium using recombinant Sendai virus
Yonemitsu, Y., Kitson, C., Ferrari, S., Farley, R., Griesenbach, U., Judd, D., Steel, R., Scheid, P., Zhu, J., Jeffery, P. K., et al. (2000) · Nature Biotechnology · doi:10.1038/79463 · Cited by 244
“, or the plasmid pCMV-luc complexed to GL-67/DOPE/DMPE-PEG 5000 (80 μg DNA/mouse) were placed as a single 100 μl bolus into the nasal cavity of male BALB/c mice (six to eight weeks), and the solution was sniffed into the lung”
MethodGill, D., Smyth, S., Goddard, C., Pringle, I., Higgins, C., Colledge, W., & Hyde, S. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301561 · Cited by 214
Optimization of Plasmid Vectors for High-Level Expression in Lung Epithelial Cells
Yew, N. S., Wysokenski, D. M., Wang, K. X., Ziegler, R. J., Marshall, J., McNeilly, D., Cherry, M., Osburn, W., & Cheng, S. H. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.5-575 · Cited by 113
Self-citationRecent Developments in mRNA-Based Protein Supplementation Therapy to Target Lung Diseases
Sahu, I., Haque, A. K. M. A., Weidensee, B., Weinmann, P., & Kormann, M. S. D. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.02.019 · Cited by 104
Zhao, H., Hemmi, H., Akira, S., Cheng, S. H., Scheule, R. K., & Yew, N. S. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2003.11.012 · Cited by 85
Self-citation
Metadata
- Authors
- Lee, E. R., Marshall, J., Siegel, C. S., Jiang, C., Yew, N. S., Nichols, M. R., Nietupski, J. B., Ziegler, R. J., Lane, M. B., Wang, K. X., Wan, N. C., Scheule, R. K., Harris, D. J., Smith, A. E., & Cheng, S. H.
- Venue
- Human Gene Therapy
- Publisher
- SAGE Publications
- Published
- 1996-09-10
- Volume
- 7
- Issue
- 14
- Pages
- 1701-1717
- ISSN
- 1043-0342 (ISSN-L)
- 1557-7422
- OpenAlex
- W2040282775
- Cited by
- 443
- References
- 34
- FWCI
- 13.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.